News

Takeda's Dengue Shot is 80% Effective in Phase III Trial

Takeda's Dengue Shot is 80% Effective in Phase III Trial

Takeda has released results from a clinical trial that found its dengue shot was 95.4% effective in preventing dengue that required hospitalization; there were five hospitalizations in the vaccine group versus 53 in the placebo group. The company will submit these phase III results for regulatory approval. With clinical trials taking place in more than 200 countries worldwide, Yourway is the partner that companies need to navigate the diverse and ever-changing global regulatory landscape.

Back to Index
Media

Upcoming Event

ISCR conference

January 23-25, 2020
Mumbai, India
Booth #16

Media

Articles

Agility and Flexibility in a Company That Provides Both Courier and Clinical Packaging Services